nadp Search Results


93
Dojindo Labs nadp nadph assay kit wst
Nadp Nadph Assay Kit Wst, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pm39089738-61-0-4?v=Dojindo+Labs
Average 93 stars, based on 1 article reviews
nadp nadph assay kit wst - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Elabscience Biotechnology nadp nadph assay kit
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Nadp Nadph Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc12684898-105-9-35?v=Elabscience+Biotechnology
Average 94 stars, based on 1 article reviews
nadp nadph assay kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology nadph tetrasodium salt
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Nadph Tetrasodium Salt, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pm31465201__cb9b00533_si_001-85-0-6?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
nadph tetrasodium salt - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Proteintech me1
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Me1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc12167773__mmc1-22-195-193?v=Proteintech
Average 93 stars, based on 1 article reviews
me1 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Thermo Fisher beta nicotinamide adenine dinucleotide phosphate reduced tetrasodium salt nadph
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Beta Nicotinamide Adenine Dinucleotide Phosphate Reduced Tetrasodium Salt Nadph, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc10707468-239-6-16?v=Thermo+Fisher
Average 91 stars, based on 1 article reviews
beta nicotinamide adenine dinucleotide phosphate reduced tetrasodium salt nadph - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

94
Proteintech anti idh2 rabbit pab
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Anti Idh2 Rabbit Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc12381242__41467_2025_62731_MOESM5_ESM-25-151-178?v=Proteintech
Average 94 stars, based on 1 article reviews
anti idh2 rabbit pab - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Proteintech idh1 antibody
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Idh1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/us09982309-2081-15-17?v=Proteintech
Average 94 stars, based on 1 article reviews
idh1 antibody - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Addgene inc k242020 lr clonase enzyme mix thermo fisher scientific
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
K242020 Lr Clonase Enzyme Mix Thermo Fisher Scientific, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pm35172131-161-249-270?v=Addgene+inc
Average 93 stars, based on 1 article reviews
k242020 lr clonase enzyme mix thermo fisher scientific - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Thermo Fisher nadph tetrasodium salt hydrate
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Nadph Tetrasodium Salt Hydrate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pm29494888-57-0-10?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
nadph tetrasodium salt hydrate - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology nadp
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Nadp, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc12785307-221-49-50?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
nadp - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

88
Thermo Fisher β nicotinamide adenine dinucleotide phosphate disodium salt
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
β Nicotinamide Adenine Dinucleotide Phosphate Disodium Salt, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc06156103-40-37-47?v=Thermo+Fisher
Average 88 stars, based on 1 article reviews
β nicotinamide adenine dinucleotide phosphate disodium salt - by Bioz Stars, 2026-08
88/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology nadp disodium salt
LINC01532 is identified as a potential <t>NADPH-metabolism-related</t> lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).
Nadp Disodium Salt, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nadp/pmc11497281__ANIE___63___e202403098___s002-25-0-6?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
nadp disodium salt - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

Image Search Results


LINC01532 is identified as a potential NADPH-metabolism-related lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).

Journal: Journal of Advanced Research

Article Title: Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma

doi: 10.1016/j.jare.2025.02.035

Figure Lengend Snippet: LINC01532 is identified as a potential NADPH-metabolism-related lncRNA in HCC drug resistance. ( A ) The expression of G6PD, ME1, ME2 and MTHFD2 was analyzed in HCC tissues and adjacent non-cancerous tissues using TCGA dataset. ( B ) Venn diagram was employed to analyze the overlap lncRNAs among G6PD-related lncRNAs, prognosis related lncRNAs and differentially expressed lncRNAs. ( C ) The expression of the eight lncRNAs was evaluated by RT-qPCR in HCC tissues and the adjacent non-tumoral tissues from our hospital. ( D ) HuH-7 cells were transfected with indicated siRNAs and cellular NADPH level was determined. ( E ) The expression of eight lncRNAs was evaluated by RT-qPCR in lenvatinib-resistant HuH-7 cells. ( F ) The LINC01532 expression was analyzed in HCC tissues and adjacent non-tumoral tissues. ( G ) Overall survival (OS) and disease-free survival (DFS) analyses based on LINC01532 levels were analyzed using data from TCGA-LIHC cohort. ( H ) OS and DFS analyses based on LINC01532 level were analyzed using data from our cohort. ( I ) RT-qPCR was performed to detect LINC01532 expression in the cytoplasmic and nuclear fractions. ( J ) The subcellular localization of LINC01532 was determined by Fluorescence in situ hybridization (FISH). Scale bar, 10 μm. ( K ) LINC01532 coding capability was performed by CPAT ( http://lilab.research.bcm.edu ).

Article Snippet: NADPH, G6PD, GSH and MDA levels were evaluated using NADP + /NADPH Assay Kit (Beyotime, China), G6PDH Activity Assay Kit (Beyotime, China), Reduced Glutathione Content Assay Kit (Solarbio, China) and Malondialdehyde (MDA) Colorimetric Assay Kit (Elabscience, China), respectively, based on the manufacturer's protocol.

Techniques: Expressing, Quantitative RT-PCR, Transfection, Fluorescence, In Situ Hybridization

LINC01532 elevates PPP flux. ( A ) Cellular NADPH level was determined in HuH-7 and MHCC97-H stably overexpressing LINC01532. ( B ) Cellular G6PD activity was evaluated in the indicated cells. ( C ) Cellular NADPH level was detected in the indicated cells. ( D ) Cellular G6PD activity was determined in the indicated cells. ( E ) Cellular GSH level was assessed in HuH-7 and MHCC97-H stably overexpressing LINC01532. ( F ) Cellular GSH level was analyzed in the indicated cells. ( G ) Oil red O staining assay (left) was performed in the indicated cells. The numbers of lipid droplets around cells were summarized (n = 50, right). ( H ) Cellular NADPH level was determined in the indicated cells treated with RRX-001. ( I ) The indicated cells were treated with RRX-001 and cellular GSH level was determined. ( J ) Cellular NADPH level was determined in the cells transfected as indicated. ( K ) Oil red O staining (left) and statistical analysis (right) were performed in HuH-7 cells as indicated.

Journal: Journal of Advanced Research

Article Title: Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma

doi: 10.1016/j.jare.2025.02.035

Figure Lengend Snippet: LINC01532 elevates PPP flux. ( A ) Cellular NADPH level was determined in HuH-7 and MHCC97-H stably overexpressing LINC01532. ( B ) Cellular G6PD activity was evaluated in the indicated cells. ( C ) Cellular NADPH level was detected in the indicated cells. ( D ) Cellular G6PD activity was determined in the indicated cells. ( E ) Cellular GSH level was assessed in HuH-7 and MHCC97-H stably overexpressing LINC01532. ( F ) Cellular GSH level was analyzed in the indicated cells. ( G ) Oil red O staining assay (left) was performed in the indicated cells. The numbers of lipid droplets around cells were summarized (n = 50, right). ( H ) Cellular NADPH level was determined in the indicated cells treated with RRX-001. ( I ) The indicated cells were treated with RRX-001 and cellular GSH level was determined. ( J ) Cellular NADPH level was determined in the cells transfected as indicated. ( K ) Oil red O staining (left) and statistical analysis (right) were performed in HuH-7 cells as indicated.

Article Snippet: NADPH, G6PD, GSH and MDA levels were evaluated using NADP + /NADPH Assay Kit (Beyotime, China), G6PDH Activity Assay Kit (Beyotime, China), Reduced Glutathione Content Assay Kit (Solarbio, China) and Malondialdehyde (MDA) Colorimetric Assay Kit (Elabscience, China), respectively, based on the manufacturer's protocol.

Techniques: Stable Transfection, Activity Assay, Staining, Transfection